From: Management of intoxicated patients – a descriptive outcome analysis of 4,267 ICU patients
Characteristic | Other diagnoses (n=105,998) | Intoxications (n=4,267) | p-value |
---|---|---|---|
Age (years) – median (IQR) | 66 (54-77) | 41 (29-53) | <0.001* |
Age category | - | - | <0.001* |
Age <65 years | 47% (49,725) | 92% (3,934) | - |
Age 65-79 years | 33% (35,431) | 6% (246) | - |
Age ≥80 years | 20% (20,842) | 2% (87) | - |
Sex | - | - | <0.001* |
Female | 45% (48,213) | 55% (2,333) | - |
Male | 54% (57,757) | 45% (1,929) | - |
Other | 0% (7) | 0% (0) | - |
Unknown | 0% (19) | 0% (3) | - |
BMI (kg/m2) – median (IQR) | 28 (23-33) | 26 (23-31) | <0.001* |
BMI categories (WHO) | - | - | <0.001* |
BMI <18.5 kg/m2 | 4% (4,617) | 4% (160) | - |
BMI 18.5 to <25 kg/m2 | 30% (30,747) | 36% (1,468) | - |
BMI 25 to <30 kg/m2 | 29% (30,027) | 30% (1,224) | - |
BMI ≥30 kg/m2 | 37% (38,416) | 31% (1,261) | - |
Ethnicity | - | - | <0.001* |
African American | 12% (12,399) | 8% (324) | - |
Asian | 1% (1,491) | 1% (45) | - |
Caucasian | 78% (81,375) | 83% (3,462) | - |
Hispanic | 4% (4,133) | 3% (112) | - |
Native American | 1% (693) | 1% (54) | - |
Other/Unknown | 5% (4,762) | 4% (162) | - |
SOFA score (pts.) – median (IQR) | 4 (2-6) | 3 (1-5) | <0.001* |
APACHE-IV (pts.) – median (IQR) | 52 (38-70) | 37 (26-54) | <0.001* |
Laboratory values – median (IQR) | - | - | - |
Maximum lactate day 1 (mmol/L) | 1.9 (1.2-3.3) | 1.6 (1.0-2.5) | <0.001* |
First lactate >2 mmol/L | 40% (12,699) | 35% (324) | <0.001* |
Maximum creatinine day 1 (mg/dL) | 1.0 (0.8-1.6) | 0.8 (0.7-1.0) | <0.001* |
Hemoglobin (g/dL) | 11.2 (9.5-12.8) | 12.4 (11.3-13.6) | <0.001* |
Platelets (G/L) | 192.0 (144.0-249.0) | 210.0 (169.0-256.0) | <0.001* |
Leucocytes (G/L) | 10.4 (7.5-14.5) | 8.7 (6.5-11.6) | <0.001* |
Diagnosis category | - | - | <0.001* |
ACS | 8% (8,343) | 0% (0) | - |
ARF | 2% (1,932) | 0% (0) | - |
Asthma/Emphysema | 4% (3,948) | 0% (0) | - |
CABG | 5% (4,771) | 0% (0) | - |
CHF | 5% (5,592) | 0% (0) | - |
CVA | 9% (9,758) | 0% (0) | - |
CV (others) | 3% (3,593) | 0% (0) | - |
Cardiac Arrest | 9% (9,135) | 0% (0) | - |
Coma | 2% (2,082) | 0% (0) | - |
DKA | 4% (4,384) | 0% (0) | - |
GI bleeding | 7% (7,277) | 0% (0) | - |
GI obstruction | 1% (1,232) | 0% (0) | - |
Neurological | 4% (4,640) | 0% (0) | - |
Overdose | 0% (0) | 100% (4,267) | - |
Pneumonia | 4% (4,577) | 0% (0) | - |
Respiratory (others) | 8% (7,970) | 0% (0) | - |
Sepsis | 17% (18,087) | 0% (0) | - |
Trauma | 6% (5,884) | 0% (0) | - |
Valvular Disease | 3% (2,793) | 0% (0) | - |
Intensive care measures | - | - | - |
Mechanical ventilation | 24% (25,280) | 26% (1,118) | <0.001* |
Vasopressor use | 15% (15,994) | 5% (197) | <0.001* |
Dialysis (first three days) | 4% (2,048) | 3% (36) | 0.26 |
Outcome | - | - | - |
AKI | 6% (4,745) | 2% (49) | <0.001* |
LOS (hours) | 45 (24-82) | 28 (18-46) | <0.001* |
LOS >7 days | 9% (9,521) | 3% (111) | <0.001* |
ICU mortality | 6% (6,827) | 0% (21) | <0.001* |
Hospital mortality | 10% (10,661) | 1% (32) | <0.001* |